Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News RenovoRx Inc RNXT

Healthcare Biotechnology
RenovoRx, Inc. is a clinical-stage biopharmaceutical company. The Company is developing targeted combination therapies for high unmet medical needs with a goal of improving therapeutic outcomes for cancer patients undergoing treatment. Its Trans-Arterial Micro-Perfusion (TAMP) therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:RNXT)

Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial

GlobeNewswire 1 day ago

RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire 7 days ago

RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians

GlobeNewswire September 25, 2024

RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP(TM) for Targeted Treatment of Locally Advanced Pancreatic Cancer

GlobeNewswire September 19, 2024

RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright's 26th Annual Global Investment Conference on September 9, 2024 in New York

GlobeNewswire August 27, 2024

RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial

GlobeNewswire August 14, 2024

RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist®

GlobeNewswire July 31, 2024

RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®

GlobeNewswire July 8, 2024

University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx's Pivotal Phase III TIGeR-PaC Clinical Trial

GlobeNewswire June 26, 2024
View More News ››

Opinion & Analysis (NDAQ:RNXT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RNXT)

An Undervalued Biotech Showing Promise

An Undervalued Biotech Showing Promise https://10xalerts.com/an-undervalued-biotech-showing-promise/
Mathew177 - October 25, 2024

RenovoRx, Inc. (RNXT): Pioneering Precision Oncology with Pr

http://beyondspx.com/2024/08/01/renovorx-inc-rnxt-pioneering-precision-oncology-with-promising-clinical-results/
MikeTester - August 1, 2024

RenovoRx’s Breakthroughs in Targeted Cancer Treatments

RenovoRx’s Breakthroughs in Targeted Cancer Treatments (NASDAQ: RNXT) ...
ElliotGH - July 16, 2024

RenovoRx Announces Acceptance for Publication

RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The...
Mathew177 - July 9, 2024

University of Nebraska Medical Center Launches Patient

University of Nebraska Medical Center Launches Patient Enrollment for RenovoRxs Pivotal Phase III TIGeR-PaC Clinical Trial (NASDAQ: RNXT)...
Mathew177 - June 26, 2024

Ascendiant Capital highlights cancer therapy, sees potential

Ascendiant Capital highlights cancer therapy, sees potential on RenovoRx stock (NASDAQ: RNXT) ...
ElliotGH - June 17, 2024
View more Bullboard ››

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed ...
View More »